Viatris, Inc. (VTRS)
19.64
-0.24
(-1.18%)
USD |
NASDAQ |
Nov 20, 16:00
19.64
0.00 (0.00%)
After-Hours: 19:15
Viatris Gross Profit (TTM) : 6.014B for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 6.014B |
| June 30, 2026 | 5.838B |
| March 31, 2026 | 5.667B |
| December 31, 2025 | 5.501B |
| September 30, 2025 | 5.322B |
| June 30, 2025 | 5.506B |
| March 31, 2025 | 5.546B |
| December 31, 2024 | 5.852B |
| September 30, 2024 | 6.148B |
| June 30, 2024 | 6.264B |
| March 31, 2024 | 6.509B |
| December 31, 2023 | 6.565B |
| September 30, 2023 | 6.376B |
| June 30, 2023 | 6.457B |
| March 31, 2023 | 6.463B |
| December 31, 2022 | 6.688B |
| September 30, 2022 | 6.943B |
| June 30, 2022 | 6.969B |
| March 31, 2022 | 6.774B |
| December 31, 2021 | 6.350B |
| September 30, 2021 | 5.707B |
| June 30, 2021 | 5.081B |
| March 31, 2021 | 4.608B |
| December 31, 2020 | 4.140B |
| September 30, 2020 | 4.335B |
| Date | Value |
|---|---|
| June 30, 2020 | 4.252B |
| March 31, 2020 | 4.201B |
| December 31, 2019 | 4.111B |
| September 30, 2019 | 3.919B |
| June 30, 2019 | 3.926B |
| March 31, 2019 | 3.951B |
| December 31, 2018 | 4.12B |
| September 30, 2018 | 4.382B |
| June 30, 2018 | 4.488B |
| March 31, 2018 | 4.728B |
| December 31, 2017 | 4.824B |
| September 30, 2017 | 4.871B |
| June 30, 2017 | 4.968B |
| March 31, 2017 | 4.909B |
| December 31, 2016 | 4.775B |
| September 30, 2016 | 4.554B |
| June 30, 2016 | 4.613B |
| March 31, 2016 | 4.480B |
| December 31, 2015 | 4.391B |
| September 30, 2015 | 4.347B |
| June 30, 2015 | 4.046B |
| March 31, 2015 | 3.812B |
| December 31, 2014 | 3.894B |
| September 30, 2014 | 3.661B |
| June 30, 2014 | 3.450B |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Pacira Biosciences, Inc. | 529.87M |
| Pfizer Inc. | 41.42B |
| Eli Lilly & Co. | 72.31B |
| Merck & Co., Inc. | 46.84B |
| Amphastar Pharmaceuticals, Inc. | 333.67M |